Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Commentary
Nature Chemical Biology 5, 436–440 (1 July 2009) | doi:10.1038/nchembio0709-436
Open access chemical and clinical probes to support drug discovery
&
Abstract
Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
